Chemical Component Summary

NameErgotamine
Identifiersn/a
FormulaC33 H35 N5 O5
Molecular Weight581.66
TypeNON-POLYMER
Isomeric SMILESC[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)Cc4ccccc4)NC(=O)[C@H]5CN([C@@H]6Cc7c[nH]c8c7c(ccc8)C6=C5)C
InChIInChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1
InChIKeyXCGSFFUVFURLIX-VFGNJEKYSA-N

Chemical Details

Formal Charge0
Atom Count78
Chiral Atom Count6
Bond Count85
Aromatic Bond Count16

Drug Info: DrugBank

DrugBank IDDB00696 
NameErgotamine
Groupsapproved
DescriptionA vasoconstrictor found in ergot of Central Europe. It is an alpha-1 selective adrenergic agonist and is commonly used in the treatment of migraine disorders.
Synonyms
  • Ergotamine tartrate
  • Ergotamina
  • (5'α)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione
  • 12'-hydroxy-2'-methyl-5'α-(phenylmethyl)ergotaman-3',6',18-trione
  • Ergotamin
Brand Names
  • Megral Tabs
  • Ergotamine Tartrate and Caffeine
  • Ergotamine
  • Cafergot Pb Sup
  • Ercaf
IndicationFor use as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants, or so called "histaminic cephalalgia".
Categories
  • Adrenergic Agents
  • Adrenergic alpha-1 Receptor Antagonists
  • Adrenergic alpha-Antagonists
  • Adrenergic Antagonists
  • Agents that produce hypertension
ATC-Code
  • N02CA02
  • N02CA52
  • N02CA72
CAS number113-15-5

Drug Targets

NameTarget SequencePharmacological ActionActions
5-hydroxytryptamine receptor 1DMSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITL...unknownagonist
5-hydroxytryptamine receptor 1BMEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKV...unknownagonist
5-hydroxytryptamine receptor 2AMDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSE...unknownagonist
Dopamine D2 receptorMDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVF...unknownagonist
Alpha-1A adrenergic receptorMVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILS...unknownpartial agonist
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
CCDC/CSDFETGAN
PubChem8223
ChEBICHEBI:64318
ChEMBLCHEMBL442
PharosCHEMBL442